IN RE: MEDICAL REVIEW PANEL NO. 25-CA-19 PROCEEDING OF RONALD LAPORTE (D) FIFTH CIRCUIT
COURT OF APPEAL
STATE OF LOUISIANA
ON APPEAL FROM THE TWENTY-FOURTH JUDICIAL DISTRICT COURT PARISH OF JEFFERSON, STATE OF LOUISIANA NO. 852-136, DIVISION "C" HONORABLE JUNE B. DARENSBURG, JUDGE PRESIDING
September 24, 2025
MARC E. JOHNSON JUDGE
Panel composed of Judges Marc E. Johnson, Stephen J. Windhorst, and John J. Molaison, Jr.
AFFIRMED IN PART; REVERSED IN PART; REMANDED WITH INSTRUCTIONS MEJ SJW JJM COUNSEL FOR PLAINTIFF/APPELLANT, RONALD LAPORTE Alexandre E. Bonin R. Christian Bonin Jean-Marc Bonin
COUNSEL FOR DEFENDANT/APPELLEE, WEST JEFFERSON HOLDINGS, LLC D/B/A WEST JEFFERSON MEDICAL CENTER Michael F. Nolan, Jr. Sarah L. Johnson
COUNSEL FOR DEFENDANT/APPELLEE, RYAN TANENBAUM, M.D. Tara S. Bourgeois Jonathan E. Thomas Valerie A. Judice JOHNSON, J.
Plaintiffs/Appellants, Peggy LaPorte and Ronell LaPorte, appeal the trial
court’s judgment that sustained peremptory exceptions of prescription filed by
Defendants/Appellees, West Jefferson Holdings, LLC d/b/a West Jefferson
Medical Center and Rian Tanenbaum, M.D., and dismissed their claims with
prejudice arising from alleged medical malpractice in the 24th Judicial District
Court, Division “C”. For the following reasons, we affirm in part, reverse in part,
and remand to the trial court with instructions.
FACTS AND PROCEDURAL HISTORY
According to the pleadings, Ronald LaPorte arrived at the emergency room
of West Jefferson Medical Center (hereinafter referred to as “WJMC”) on
November 18, 2022, after his primary care doctor instructed him to report to the
emergency room due to an abnormal hemoglobin level. He was admitted to
WJMC for a possible gastrointestinal (“GI”) bleed and given a transfusion of red
blood cells. Mr. LaPorte was then referred for a GI evaluation.
On November 22, 2022, Dr. Rian Tanenbaum, a gastroenterologist,
performed a colonoscopy with a polypectomy on Mr. LaPorte due to iron
deficiency anemia secondary to chronic blood loss. A 20 mm polyp and a 10 mm
polyp were found and removed from Mr. LaPorte’s cecum. Mr. LaPorte was
discharged from WJMC on the same date.
Four days later, Mr. LaPorte was readmitted to WJMC on November 26,
2022 with complaints of rectal bleeding following his November 22, 2022
procedure. He was diagnosed in the emergency room with acute GI bleeding and
was infused with two units of blood and one unit of platelets. However, after being
subsequently diagnosed with acute leukemia, Mr. LaPorte was transferred to
Tulane University Hospital for oncology treatment on November 28, 2022.
Mr. LaPorte was admitted to WJMC for a third time on December 12, 2022
25-CA-19 1 for acute GI bleeding. Palliative Care Medicine consulted with Mr. LaPorte and
his family regarding his leukemia diagnosis and grave condition. On December
20, 2022, Mr. LaPorte was discharged to home hospice care. He later died on
January 17, 2023.
On January 17, 2024, Peggy LaPorte (Mr. LaPorte’s surviving widow) and
Ronell LaPorte (Mr. LaPorte’s surviving daughter)—(hereinafter collectively
referred to as “Appellants”)—instituted a request for a medical malpractice review
panel1 with the Louisiana Division of Administration against WJMC and Dr.
Tanenbaum. In their request, Appellants alleged that the polyp removal performed
on Mr. LaPorte during the November 22nd colonoscopy was unnecessary, without
informed consent, and against the standard of care for a patient suffering from
chronic blood loss and anemia. They asserted that the procedure caused various
damages, including wrongful death and survival damages. Appellants
subsequently filed a petition to institute discovery in the trial court on March 7,
2024, requesting compulsory process and discovery proceedings, pursuant to La.
R.S. 40:1231.8, et seq.
In opposition, WJMC filed a peremptory exception of prescription on April,
25, 2024, prior to any determination in the administrative proceeding with the
Louisiana Division of Administration. In its exception, it argued that Appellants’
medical review panel request is prescribed on its face. It contended that the
alleged malpractice occurred on November 22, 2022, the date of the colonoscopy
procedure; yet, Appellants’ complaint was not filed until January 17, 2024, which
was well over one year after the date of Mr. LaPorte’s colonoscopy and
polypectomy. WJMC maintained that, based upon Mr. LaPorte’s medical records,
Appellants had actual or constructive knowledge that Mr. LaPorte’s injuries,
1 The request will interchangeably be referred to as “complaint” or “petition” throughout the opinion.
25-CA-19 2 including his imminent death, may have been caused by medical malpractice
resulting from the colonoscopy as soon as November 22, 2022 but no later than
December 20, 2022—more than one year prior to the date of filing their complaints
for survival and wrongful death damages.
Dr. Tanenbaum also filed an exception of prescription, alleging that
Appellants’ complaint is prescribed on its face. He contended that Appellants were
required to allege the facts with particularity that showed they were unaware of the
November 22, 2022 malpractice before their January 17, 2024 filing, and they
failed to do so in their complaint. He maintained that Appellants had actual or
constructive knowledge sufficient to excite their attention of their wrongful death
and survival action claims no later than December 20, 2023.
Appellants did not file a brief in opposition to either of the exceptions of
prescription.
A hearing on the exceptions was held on June 17, 2024. Counsel for
Defendants argued and introduced evidence at the hearing. Although counsel for
Appellants was present at the hearing, the trial court did not allow him to present
any argument because no opposition brief had been filed, thereby forfeiting oral
argument. At the conclusion of the hearing, the trial court sustained Defendants’
exceptions of prescription. A written judgment to that effect was rendered on the
same date, dismissing Appellants’ complaint with prejudice. The instant appeal
followed.
ASSIGNMENTS OF ERROR2
On appeal, Appellants allege that the trial court erred as a matter of law in
finding that their wrongful death claims were prescribed; and, the trial court was
2 We note that Defendants assigned their own errors for review in their appellee briefs to this Court. However, Defendants did not file an answer or a motion to dismiss with this Court for consideration of their assignments of error. Therefore, those issues were not properly raised for consideration, and this opinion will not address Defendants’ assignments of error.
25-CA-19 3 clearly wrong and unreasonable in finding, on the limited documentary record, that
their survival action claims were prescribed.
LAW AND ANALYSIS
General Exception of Prescription Law
An exception of prescription is a type of peremptory exception. The
function of the peremptory exception is to have the plaintiff’s action declared
legally nonexistent or barred by the effect of law, and hence this exception tends to
dismiss or defeat the action. Ruffins v. HAZA Foods of Louisiana, LLC, 21-619
(La. App. 5 Cir. 5/25/22), 341 So.3d 1259, 1262, citing Farber v. Bobear, 10-985
(La. App. 4 Cir. 1/19/11), 56 So.3d 1061, 1069. Prescriptive statutes are strictly
Free access — add to your briefcase to read the full text and ask questions with AI
IN RE: MEDICAL REVIEW PANEL NO. 25-CA-19 PROCEEDING OF RONALD LAPORTE (D) FIFTH CIRCUIT
COURT OF APPEAL
STATE OF LOUISIANA
ON APPEAL FROM THE TWENTY-FOURTH JUDICIAL DISTRICT COURT PARISH OF JEFFERSON, STATE OF LOUISIANA NO. 852-136, DIVISION "C" HONORABLE JUNE B. DARENSBURG, JUDGE PRESIDING
September 24, 2025
MARC E. JOHNSON JUDGE
Panel composed of Judges Marc E. Johnson, Stephen J. Windhorst, and John J. Molaison, Jr.
AFFIRMED IN PART; REVERSED IN PART; REMANDED WITH INSTRUCTIONS MEJ SJW JJM COUNSEL FOR PLAINTIFF/APPELLANT, RONALD LAPORTE Alexandre E. Bonin R. Christian Bonin Jean-Marc Bonin
COUNSEL FOR DEFENDANT/APPELLEE, WEST JEFFERSON HOLDINGS, LLC D/B/A WEST JEFFERSON MEDICAL CENTER Michael F. Nolan, Jr. Sarah L. Johnson
COUNSEL FOR DEFENDANT/APPELLEE, RYAN TANENBAUM, M.D. Tara S. Bourgeois Jonathan E. Thomas Valerie A. Judice JOHNSON, J.
Plaintiffs/Appellants, Peggy LaPorte and Ronell LaPorte, appeal the trial
court’s judgment that sustained peremptory exceptions of prescription filed by
Defendants/Appellees, West Jefferson Holdings, LLC d/b/a West Jefferson
Medical Center and Rian Tanenbaum, M.D., and dismissed their claims with
prejudice arising from alleged medical malpractice in the 24th Judicial District
Court, Division “C”. For the following reasons, we affirm in part, reverse in part,
and remand to the trial court with instructions.
FACTS AND PROCEDURAL HISTORY
According to the pleadings, Ronald LaPorte arrived at the emergency room
of West Jefferson Medical Center (hereinafter referred to as “WJMC”) on
November 18, 2022, after his primary care doctor instructed him to report to the
emergency room due to an abnormal hemoglobin level. He was admitted to
WJMC for a possible gastrointestinal (“GI”) bleed and given a transfusion of red
blood cells. Mr. LaPorte was then referred for a GI evaluation.
On November 22, 2022, Dr. Rian Tanenbaum, a gastroenterologist,
performed a colonoscopy with a polypectomy on Mr. LaPorte due to iron
deficiency anemia secondary to chronic blood loss. A 20 mm polyp and a 10 mm
polyp were found and removed from Mr. LaPorte’s cecum. Mr. LaPorte was
discharged from WJMC on the same date.
Four days later, Mr. LaPorte was readmitted to WJMC on November 26,
2022 with complaints of rectal bleeding following his November 22, 2022
procedure. He was diagnosed in the emergency room with acute GI bleeding and
was infused with two units of blood and one unit of platelets. However, after being
subsequently diagnosed with acute leukemia, Mr. LaPorte was transferred to
Tulane University Hospital for oncology treatment on November 28, 2022.
Mr. LaPorte was admitted to WJMC for a third time on December 12, 2022
25-CA-19 1 for acute GI bleeding. Palliative Care Medicine consulted with Mr. LaPorte and
his family regarding his leukemia diagnosis and grave condition. On December
20, 2022, Mr. LaPorte was discharged to home hospice care. He later died on
January 17, 2023.
On January 17, 2024, Peggy LaPorte (Mr. LaPorte’s surviving widow) and
Ronell LaPorte (Mr. LaPorte’s surviving daughter)—(hereinafter collectively
referred to as “Appellants”)—instituted a request for a medical malpractice review
panel1 with the Louisiana Division of Administration against WJMC and Dr.
Tanenbaum. In their request, Appellants alleged that the polyp removal performed
on Mr. LaPorte during the November 22nd colonoscopy was unnecessary, without
informed consent, and against the standard of care for a patient suffering from
chronic blood loss and anemia. They asserted that the procedure caused various
damages, including wrongful death and survival damages. Appellants
subsequently filed a petition to institute discovery in the trial court on March 7,
2024, requesting compulsory process and discovery proceedings, pursuant to La.
R.S. 40:1231.8, et seq.
In opposition, WJMC filed a peremptory exception of prescription on April,
25, 2024, prior to any determination in the administrative proceeding with the
Louisiana Division of Administration. In its exception, it argued that Appellants’
medical review panel request is prescribed on its face. It contended that the
alleged malpractice occurred on November 22, 2022, the date of the colonoscopy
procedure; yet, Appellants’ complaint was not filed until January 17, 2024, which
was well over one year after the date of Mr. LaPorte’s colonoscopy and
polypectomy. WJMC maintained that, based upon Mr. LaPorte’s medical records,
Appellants had actual or constructive knowledge that Mr. LaPorte’s injuries,
1 The request will interchangeably be referred to as “complaint” or “petition” throughout the opinion.
25-CA-19 2 including his imminent death, may have been caused by medical malpractice
resulting from the colonoscopy as soon as November 22, 2022 but no later than
December 20, 2022—more than one year prior to the date of filing their complaints
for survival and wrongful death damages.
Dr. Tanenbaum also filed an exception of prescription, alleging that
Appellants’ complaint is prescribed on its face. He contended that Appellants were
required to allege the facts with particularity that showed they were unaware of the
November 22, 2022 malpractice before their January 17, 2024 filing, and they
failed to do so in their complaint. He maintained that Appellants had actual or
constructive knowledge sufficient to excite their attention of their wrongful death
and survival action claims no later than December 20, 2023.
Appellants did not file a brief in opposition to either of the exceptions of
prescription.
A hearing on the exceptions was held on June 17, 2024. Counsel for
Defendants argued and introduced evidence at the hearing. Although counsel for
Appellants was present at the hearing, the trial court did not allow him to present
any argument because no opposition brief had been filed, thereby forfeiting oral
argument. At the conclusion of the hearing, the trial court sustained Defendants’
exceptions of prescription. A written judgment to that effect was rendered on the
same date, dismissing Appellants’ complaint with prejudice. The instant appeal
followed.
ASSIGNMENTS OF ERROR2
On appeal, Appellants allege that the trial court erred as a matter of law in
finding that their wrongful death claims were prescribed; and, the trial court was
2 We note that Defendants assigned their own errors for review in their appellee briefs to this Court. However, Defendants did not file an answer or a motion to dismiss with this Court for consideration of their assignments of error. Therefore, those issues were not properly raised for consideration, and this opinion will not address Defendants’ assignments of error.
25-CA-19 3 clearly wrong and unreasonable in finding, on the limited documentary record, that
their survival action claims were prescribed.
LAW AND ANALYSIS
General Exception of Prescription Law
An exception of prescription is a type of peremptory exception. The
function of the peremptory exception is to have the plaintiff’s action declared
legally nonexistent or barred by the effect of law, and hence this exception tends to
dismiss or defeat the action. Ruffins v. HAZA Foods of Louisiana, LLC, 21-619
(La. App. 5 Cir. 5/25/22), 341 So.3d 1259, 1262, citing Farber v. Bobear, 10-985
(La. App. 4 Cir. 1/19/11), 56 So.3d 1061, 1069. Prescriptive statutes are strictly
construed against prescription and in favor of the claim. Henry v. Southwest
Airlines, 23-522 (La. App. 5 Cir. 7/31/24), 392 So.3d 1176, 1179, writ denied, 24-
1081 (La. 11/20/24), 396 So.3d 68. Of the possible constructions of a prescriptive
statute, the one that maintains enforcement of the claim, instead of the one that
bars enforcement, should be adopted. Id.
The burden of proof in an exception of prescription lies with the party
asserting it; however, where the petition shows on its face that it has prescribed,
the burden shifts to the plaintiff to prove the prescriptive period has been
interrupted or suspended. McClellan v. Premier Nissan, L.L.C., 14-726 (La. App.
5 Cir. 2/11/15), 167 So.3d 934, 935. At the trial of the exception of prescription,
evidence may be introduced to support or controvert any of the objections pleaded,
when the grounds thereof do not appear from the petition. Bailey v. Pinnacle
Polymers, LLC, 24-490 (La. App. 5 Cir. 4/2/25), 412 So.3d 1063, 1076, citing La.
C.C.P. art. 931. If evidence is introduced at the hearing on the peremptory
exception of prescription, the trial court’s findings of fact are reviewed under the
manifest error/clearly wrong standard of review. Id. If the findings are reasonable
in light of the record reviewed in its entirety, an appellate court may not reverse,
25-CA-19 4 even though convinced that had it been sitting as the trier of fact, it would have
weighed the evidence differently. Id. In the absence of evidence, the exception of
prescription must be decided on the well-pleaded allegations of material facts set
forth in the petition, which are accepted as true. Ruffins, supra.
In this matter, Defendants introduced evidence at the hearing on the
exception of prescription, which was admitted by the trial court. Because evidence
was introduced and accepted, we must decide this matter under the manifest
error/clearly wrong standard of review.
Wrongful Death Claim
Appellants allege that the trial court erred in finding that their wrongful
death claim was prescribed under La. R.S. 9:5628. They argue that Mr. LaPorte
died on January 17, 2023, and they filed their wrongful death claim on January 17,
2024, within one year of Mr. Laporte’s death. They contend that wrongful death
actions prescribe within one-year of the decedent’s death, pursuant to La. C.C. art.
2315.2. As a result, Appellants maintain that their wrongful death claim is not
prescribed on the face of their complaint.
Defendants aver that the trial court properly sustained their exceptions of
prescription. Dr. Tanenbaum argues that Appellants’ complaint failed to assert any
fault against him for performing the colonoscopy with polypectomy on November
22, 2022 that caused or contributed to Mr. LaPorte’s death on January 17, 2023, or
identify any medical records to support such an allegation. He contends that,
because Appellants’ complaint does not contain the essential element of causation
as to their wrongful death claim, the claim is invalid; and it was reasonable for the
trial court to infer that Mr. LaPorte’s cause of death was leukemia.
WJMC argues that, based upon Mr. LaPorte’s medical records, Appellants
had actual or constructive knowledge of alleged medical malpractice as early as
November 22, 2022 but no later than December 20, 2022. It maintains that the
25-CA-19 5 family and Mr. LaPorte were advised of the severity of his illness prior to his
death. Thus, WJMC contends the alert excited Appellants’ attention that Mr.
LaPorte continued to suffer from a GI bleed since November 22, 2022 and gave
them constructive knowledge that the alleged malpractice was potentially a cause
of his death.
La. C.C. art. 2315.2 provides, in pertinent part,
A. If a person dies due to the fault of another, suit may be brought by the following persons to recover damages which they sustained as a result of the death: (1) The surviving spouse and child or children of the deceased, or either the spouse or the child or children. *** B. The right of action granted by this Article prescribes one year from the death of the deceased.
Although wrongful death claims arising from medical malpractice are procedurally
governed by the Louisiana Medical Malpractice Act, the prescriptive periods set
forth in La. R.S. 9:5628 do not apply to wrongful death claims. Med. Review
Panel for Bush, 21-954 (La. 5/13/22), 339 So.3d 1118, 1123; Jimenez v. Cattie, 25-
61 (La. App. 5 Cir. 7/30/25), 2025 WL 2159981. The commencement and running
of the prescriptive period for the wrongful death action is controlled by the one-
year liberative period applicable to delictual actions. Id, citing Taylor v. Giddens,
618 So.2d 834, 836 (La. 1993).
In the case at bar, Appellants filed their complaint on January 17, 2024.
They alleged that Mr. LaPorte died on January 17, 2023, and they sustained
damages from his wrongful death. The complaint was filed within one year of Mr.
LaPorte’s death. Thus, according to La. C.C. art. 2315.2(B), we find that
Appellants timely filed their wrongful death claim with the Louisiana Division of
Administration. Therefore, we find that the trial court erred in sustaining
Defendants’ exceptions of prescription as to Appellants’ wrongful death claim.
However, we raise a peremptory exception of no cause of action on our own
25-CA-19 6 motion.
A cause of action, for purposes of the peremptory exception, is defined as
the operative facts that give rise to the plaintiff’s right to judicially assert an action
against the defendant. Labruzzo v. State, 23-194 (La. App. 5 Cir. 5/22/24), 388
So.3d 1208, 1214. The function of the peremptory exception of no cause of action
is to question whether the law extends a remedy to anyone under the factual
allegations of the petition. Id. The failure to disclose a cause of action may be
noticed by either the trial or appellate court on its own motion. La. C.C.P. art. 927.
A petition should not be dismissed for failure to state a cause of action, unless it
appears beyond a doubt that the plaintiff can prove no set of facts in support of any
claim that would entitle him to relief. Labruzzo, supra.
In reference to their wrongful death claim, Appellants’ request for a medical
malpractice review panel simply stated, “Claimants have damages for wrongful
death… .” Consequently, we find that there are no operative facts stated in the
complaint that give rise to Appellants’ right to judicially assert a wrongful death
claim against Defendants and sustain the exception of no cause of action. We
further find that amendment of Appellants’ request can cure the lack of operative
facts needed to assert a wrongful death claim against Defendants. Therefore, we
remand the matter to the trial court and order it to allow Appellants an opportunity
to amend their wrongful death claim within their request within the time delay set
by the court. (See, La. C.C.P. art. 934 that states, “[w]hen the grounds of the
objection pleaded by the peremptory exception may be removed by amendment of
the petition, the judgment sustaining the exception shall order such amendment
within the delay allowed by the court.”)
Survival Action Claim
Appellants allege that the trial court erred in sustaining the exceptions of
prescription as to their survival action claim. They assert that the trial court
25-CA-19 7 erroneously relied upon representations made in partial medical records from Mr.
LaPorte’s hospitalization to conclude that they had constructive notice Mr. LaPorte
was a victim of medical malpractice. They contend the partial medical records do
not demonstrate that Mr. LaPorte’s family had any reasonable suspicion that Mr.
LaPorte was the victim of a tort prior to his death. Appellants also argue that mere
apprehension something may have been wrong is insufficient to commence the
running of prescription, unless the plaintiff knew or should have known through
the exercise of reasonable diligence that his problem may have been caused by acts
of malpractice. They claim that the medical records indicate that Mr. LaPorte’s GI
bleed was a secondary concern to his acute leukemia, and the family was unaware
of the unexpected outcome from the procedure.
Defendants again aver that the trial court properly sustained their exceptions
of prescription. Dr. Tanenbaum asserts that Appellants’ complaint failed to allege
with particularity that they were unaware of the alleged malpractice prior to any
supposed date of discovery. He contends that Appellants specifically state in their
complaint that the alleged malpractice occurred on November 22, 2022; yet, they
make no claim that the alleged malpractice was discovered at a later date. He
maintains that, since Appellants failed to allege that they were unaware of the
alleged malpractice until a later date of discovery and the delay in discovering the
alleged malpractice was reasonable, their complaint is prescribed on its face.
WJMC argues that Appellants wrongful death claim is prescribed on its face
because it was filed more than a year after the alleged malpractice date. It
contends that Appellants had actual or constructive knowledge by November 22,
2022 that Mr. LaPorte’s injuries may have been caused by medical malpractice
because the injuries were immediately apparent within days of the surgery, and Mr.
LaPorte sought follow-up treatment on later visits to the emergency room. WJMC
maintains that, because Appellants failed to present any evidence that their survival
25-CA-19 8 claim was not prescribed, Appellants failed to carry their burden of proving that
their claim was timely filed.
La. R.S. 9:5628 sets forth the applicable prescriptive period for survival
actions as follows:
A. No action for damages for injury or death against any physician, chiropractor, nurse, licensed midwife practitioner, dentist, psychologist, optometrist, hospital or nursing home duly licensed under the laws of the state, or community blood center or tissue bank as defined in R.S. 40:1231(A), whether based upon tort, or breach of contract, or otherwise, arising out of patient care shall be brought unless filed within one year from the date of the alleged act, omission, or neglect, or within one year from the date of discovery of the alleged act, omission, or neglect; however, even as to claims filed within one year from the date of such discovery, in all events such claims shall be filed at the latest within a period of three years from the date of the alleged act, omission, or neglect.
La. R.S. 9:5628 has been referred to as a “tripartite prescriptive provision,”
meaning that the statute has three parts. In re Medical Review Panel Proceedings
of Glover, 17-201 (La. App. 5 Cir. 10/25/17), 229 So.3d 655, 663, citing In re:
Medical Review Panel for Claim of Moses, 00-2643 (La. 5/25/01), 788 So.2d 1173.
First, one-year prescriptive period, which follows the same time frame as a
traditional tort, is the general rule. Id. Second, when an injury is not immediate
and apparent, there is a discovery exception to the general rule, known as contra
non valentum, providing that such actions prescribe one year from the date of
discovery of the alleged act, omission, or neglect. Id. Third, all claims are subject
to a peremptive period of three years, regardless of discovery. Id.
Here, Appellants alleged that the date of Defendants’ malpractice was
November 22, 2022. However, they did not file their complaint of their survival
action with the Louisiana Division of Administration until January 17, 2024. The
complaint is prescribed on its face because it was not filed within one year of the
alleged act. The burden then shifted to Appellants to prove that the prescriptive
period had been interrupted or suspended. See, McClellan, supra. Appellants
25-CA-19 9 failed to present any evidence of interruption or suspension of prescription to the
trial court for consideration, effectively failing to meet their burden of proving that
their survival action claim was timely filed.3 After considering the evidence
presented by Defendants, which included Appellants’ request for a medical
malpractice review panel and Mr. LaPorte’s medical records, we find that the trial
court properly sustained Defendants’ exceptions of prescription in regards to
Appellants’ survival action claim.
DECREE
For the foregoing reasons, we affirm the trial court’s judgment in part and
reverse in part. The matter is remanded to the trial court for compliance with the
instructions set forth in this opinion.
AFFIRMED IN PART; REVERSED IN PART; REMANDED WITH INSTRUCTIONS
3 Appellants’ request described the alleged malpractice and their damages by stating: Ronald Laporte arrived WJMC emergency room on November 18, 2022 on instruction from his primary care facility because he had a hemoglobin level of 5.0. Mr. Laporte and his family advised the emergency room team that he was receiving treatment for anemia for several months. Mr. Laporte was admitted to WJMC after receiving a transfusion of PRBC and referred for a GI evaluation. During the colonoscopy performed by Rian M. Tanenbaum on November 22, 2022, Dr. Tanenbaum removed a 20mm polyp and a 10 mm polyp from Mr. Laporte’s cecum while investigation reasons for Mr. Laporte’s iron deficiency anemia secondary to chronic blood loss. Mr. Laporte was subsequently diagnosed with acute leukemia. He died on January 17, 2023. *** Rian M. Tanenbaum, M.D. and/or West Jefferson Medical Center on information and belief performed an unnecessary surgical procedure, i.e., the polyp removal, without the informed consent of the patient and his family and against the standard of care for a patient suffering from chronic blood loss and anemia…Mr. Laporte was subsequently readmitted to the hospital. He passed away on January 17, 2023. Claimants have damages for wrongful death, mental anguish, emotional stress, possible costs, and survival damages for pain and suffering, mental anguish, emotional stress, and other damages to be discovered.
25-CA-19 10 SUSAN M. CHEHARDY CURTIS B. PURSELL
CHIEF JUDGE CLERK OF COURT
SUSAN S. BUCHHOLZ FREDERICKA H. WICKER CHIEF DEPUTY CLERK JUDE G. GRAVOIS MARC E. JOHNSON STEPHEN J. WINDHORST LINDA M. TRAN JOHN J. MOLAISON, JR. FIRST DEPUTY CLERK SCOTT U. SCHLEGEL TIMOTHY S. MARCEL FIFTH CIRCUIT MELISSA C. LEDET JUDGES 101 DERBIGNY STREET (70053) DIRECTOR OF CENTRAL STAFF POST OFFICE BOX 489 GRETNA, LOUISIANA 70054 (504) 376-1400
(504) 376-1498 FAX www.fifthcircuit.org
NOTICE OF JUDGMENT AND CERTIFICATE OF DELIVERY I CERTIFY THAT A COPY OF THE OPINION IN THE BELOW-NUMBERED MATTER HAS BEEN DELIVERED IN ACCORDANCE WITH UNIFORM RULES - COURT OF APPEAL, RULE 2-16.4 AND 2-16.5 THIS DAY SEPTEMBER 24, 2025 TO THE TRIAL JUDGE, CLERK OF COURT, COUNSEL OF RECORD AND ALL PARTIES NOT REPRESENTED BY COUNSEL, AS LISTED BELOW:
25-CA-19 E-NOTIFIED 24TH JUDICIAL DISTRICT COURT (CLERK) HONORABLE JUNE B. DARENSBURG (DISTRICT JUDGE) ALEXANDRE E. BONIN (APPELLANT) JEAN-MARC BONIN (APPELLANT) R. CHRISTIAN BONIN (APPELLANT) MICHAEL F. NOLAN, JR. (APPELLEE) SARAH L. JOHNSON (APPELLEE) JONATHAN E. THOMAS (APPELLEE) TARA S. BOURGEOIS (APPELLEE) VALERIE A. JUDICE (APPELLEE)
MAILED PAUL A. BONIN (APPELLANT) ATTORNEY AT LAW 4224 CANAL STREET NEW ORLEANS, LA 70119